Clinical Investigations and Precision Therapeutics Research Program

Program Leaders: Howard L. Kaufman, MD, FACS and Shridar Ganesan, MD, PhD
 

Overall Goals:

The Clinical Investigations and Precision Therapeutics Program is structured to encourage and promote maximum scientific interactions among clinical, population and laboratory investigators, and provides a platform to facilitate rapid movement of laboratory discoveries into clinical trials.

Specific Aims:

  • To develop and validate therapeutic approaches targeting oncogenic tumor cell survival and proliferation mechanisms.
  • To develop therapeutic approaches that modulate cancer mechanisms of stress sensitivity and resistance.
  • To develop therapeutic approaches that target the microenvironment and immune surveillance.
  • To develop approaches to determine, calibrate, and validate biological activity and biomarkers of therapeutic approaches and preventive therapeutics.

Useful Links: